Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “New York”

XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)Active Not Recruiting
NCT05881278NAUpdated Aug 17, 2026
Sponsor: XVIVO Perfusion
Heart Failure · Transplant; Failure, Heart
United States
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerRecruiting
NCT06532279Phase 2Updated Aug 17, 2026
Sponsor: NRG Oncology
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Head and Neck Squamous Cell Carcinoma
United States
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerRecruiting
NCT06952660Phase 4Updated Aug 17, 2026
Sponsor: Pfizer
Cervical Cancer
United States, Puerto Rico
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerRecruiting
NCT07221357Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Bristol-Myers Squibb
Untreated, Unresectable, or Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureRecruiting
NCT06310031NAUpdated Aug 17, 2026
Sponsor: BrioHealth Solutions, Inc.
Cardiovascular Diseases · Heart Diseases · Heart Failure
United States
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerRecruiting
NCT05624996Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Locally Advanced Lung Non-Small Cell Carcinoma · Stage IIB Lung Cancer AJCC v8 · Stage III Lung Cancer AJCC v8
United States, Canada
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)Recruiting
NCT05254743Phase 3Updated Aug 17, 2026
Sponsor: Loxo Oncology, Inc.
Chronic Lymphocytic Leukemia · Leukemia, Lymphocytic · Leukemia, B-cell · Small Lymphocytic Lymphoma
United States, Argentina, Australia, Austria, Belgium +18 more
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialRecruiting
NCT05327686Phase 2Updated Aug 17, 2026
Sponsor: NRG Oncology
Metastatic Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8 · Unresectable Renal Cell Carcinoma
United States, Australia, Canada, Ireland
A Study to Learn About the Safety of PENBRAYA During PregnancyRecruiting
NCT07768163N/AUpdated Aug 17, 2026
Sponsor: Pfizer
Meningococcal Disease
United States
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialActive Not Recruiting
NCT04513717Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8
United States, Canada
An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive Not Recruiting
NCT02955940Phase 2Updated Aug 17, 2026
Sponsor: Incyte Corporation
Pancreatic Cancer · Colorectal Cancer (CRC) · Breast Cancer · Lung Cancer
United States, Poland
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderRecruiting
NCT06793397Phase 3Updated Aug 17, 2026
Sponsor: Cybin IRL Limited
Major Depressive Disorder (MDD) · Depression in Adults · Depression - Major Depressive Disorder · Depression Disorders
United States, Australia, Czechia, Germany, Greece +3 more
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyRecruiting
NCT06541704Phase 3Updated Aug 17, 2026
Sponsor: Regeneron Pharmaceuticals
Age-related Macular Degeneration (AMD) · Geographic Atrophy (GA)
United States, Australia, Austria, Canada, France +6 more
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyActive Not Recruiting
NCT05053152Phase 2Updated Aug 17, 2026
Sponsor: NRG Oncology
Oligometastatic Prostate Carcinoma · Prostate Adenocarcinoma · Prostate Ductal Adenocarcinoma · Prostate Intraductal Carcinoma
United States, Canada
rTMS and Cognitive-behavioral Therapy for Cocaine Use DisorderRecruiting
NCT05974202NAUpdated Aug 17, 2026
Sponsor: New York State Psychiatric Institute
Cocaine Use · Cocaine Dependence · Cocaine Use Disorder · Cocaine Use Disorder, Moderate
United States
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Recruiting
NCT06072612Phase 3Updated Aug 17, 2026
Sponsor: BriaCell Therapeutics Corporation
Breast Cancer · Metastatic Breast Cancer · Breast Neoplasm · Breast Cancer Metastatic
United States
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruiting
NCT04398628N/AUpdated Aug 17, 2026
Sponsor: American Thrombosis and Hemostasis Network
Hematologic Disorder · Bleeding Disorder · Connective Tissue Disorder · Hemophilia
United States
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialActive Not Recruiting
NCT04134260Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Prostate Adenocarcinoma · Stage I Prostate Cancer AJCC v8 · Stage II Prostate Cancer AJCC v8 · Stage III Prostate Cancer AJCC v8
United States, Canada
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or ObesityActive Not Recruiting
NCT07311850Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Obesity and Overweight
United States, Bulgaria, Canada, Czechia, Germany +5 more
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityRecruiting
NCT04804644Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Metastatic Lung Small Cell Carcinoma · Metastatic Malignant Neoplasm in the Brain · Recurrent Lung Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States, Canada
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)Recruiting
NCT04929223Phase 1Updated Aug 17, 2026
Sponsor: Hoffmann-La Roche
Metastatic Colorectal Cancer
United States, Australia, Canada, Denmark, Germany +6 more
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialActive Not Recruiting
NCT05050084Phase 3Updated Aug 17, 2026
Sponsor: NRG Oncology
Prostate Adenocarcinoma
United States, Canada
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaRecruiting
NCT05112601Phase 2Updated Aug 14, 2026
Sponsor: National Cancer Institute (NCI)
Endometrial Adenocarcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Endometrioid Adenocarcinoma
United States
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab AdizutecanRecruiting
NCT07196644Phase 2Updated Aug 14, 2026
Sponsor: AbbVie
Solid Tumors Harboring MET Amplification
United States, Israel, Japan, South Korea, Spain
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community SettingRecruiting
NCT06581328Phase 4Updated Aug 14, 2026
Sponsor: Takeda
Ulcerative Colitis · Crohn's Disease
United States

Previous page Next page